Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

Ziad Farah, Sabreen Ali, Fiona Price-Kuehne, Charles G Mackworth-Young Department of Rheumatology, Charing Cross Hospital, London, UKObjectives: To evaluate the long-term efficacy and safety of tocilizumab (TCZ) in clinical patients with rheumatoid arthritis (RA) refractory to synthetic disease-modi...

Full description

Saved in:
Bibliographic Details
Main Authors: Farah Z, Ali S, Price-Kuehne F, Mackworth-Young CG
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/fe4f2ae821c34e66abc3d3e248d8dcde
Tags: Add Tag
No Tags, Be the first to tag this record!